230 related articles for article (PubMed ID: 21574055)
1. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
[TBL] [Abstract][Full Text] [Related]
4. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy.
Taunk NK; Goyal S; Moran MS; Yang Q; Parikh R; Haffty BG
Radiother Oncol; 2010 Aug; 96(2):204-8. PubMed ID: 20338651
[TBL] [Abstract][Full Text] [Related]
6. COX2 overexpression is a prognostic marker for Stage III breast cancer.
Kim HS; Moon HG; Han W; Yom CK; Kim WH; Kim JH; Noh DY
Breast Cancer Res Treat; 2012 Feb; 132(1):51-9. PubMed ID: 21533532
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
9. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
[TBL] [Abstract][Full Text] [Related]
13. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of Skp2 and p27 in human breast cancer.
Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
[TBL] [Abstract][Full Text] [Related]
16. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
Mulligan AM; O'Malley FP; Ennis M; Fantus IG; Goodwin PJ
Breast Cancer Res Treat; 2007 Nov; 106(1):39-47. PubMed ID: 17221153
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Wauters CA; Strobbe LJ; Mandigers CM; Bult P; Oyen WJ; van der Graaf WT; van Laarhoven HW
PLoS One; 2015; 10(2):e0117745. PubMed ID: 25680198
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
Mu L; Tuck D; Katsaros D; Lu L; Schulz V; Perincheri S; Menato G; Scarampi L; Harris L; Yu H
Breast Cancer Res Treat; 2012 May; 133(1):321-31. PubMed ID: 22297468
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
